Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) constitute a drug class primarily developed for the treatment of subjects with type 2 diabetes, although they have also provided significant benefit for subjects with obesity without underlying diabetes. Individuals with psychotic di...

Descripción completa

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Michailidis, Theodoros, Dimosiari, Athina, Fragakis, Nikolaos, Tse, Gary, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045529/
https://www.ncbi.nlm.nih.gov/pubmed/36979648
http://dx.doi.org/10.3390/biomedicines11030669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045529/
https://www.ncbi.nlm.nih.gov/pubmed/36979648
http://dx.doi.org/10.3390/biomedicines11030669

Ejemplares similares